Medicus Pharma Ltd.

Medicus Pharma Ltd. was incorporated on April 30, 2008, in Ontario, Canada, initially as Interactive Capital Partners Corporation. On September 29, 2023, the company completed a business combination with SkinJect Inc., a Pennsylvania-based company, which resulted in SkinJect becoming a wholly owned operating subsidiary and the company being renamed Medicus Pharma Ltd. This transaction was a reverse takeover by SkinJect's former shareholders. The company's common shares began trading on the TSX Venture Exchange under the symbol "MDCX" on October 11, 2023. On November 15, 2024, Medicus Pharma Ltd. completed its initial public offering in the United States, and its common shares and public warrants, with an exercise price of $4.64 and an expiration date of November 15, 2029, commenced trading on Nasdaq under the symbols "MDCX" and "MDCXW," respectively. The company's common shares were voluntarily delisted from the TSXV on February 21, 2025, but continue to be listed on Nasdaq. On August 29, 2025, Medicus Pharma Ltd. acquired 98.6% of the issued and outstanding shares of Antev for approximately US$2.97 million in cash and 1,603,164 common shares of Medicus.